Cargando…

Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios

BACKGROUND: Ageing populations and rising prevalence of non-communicable diseases (NCDs) increasingly contribute to the growing cost burden facing European healthcare systems. Few studies have attempted to quantify the future magnitude of this burden at the European level, and none of them consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Goryakin, Yevgeniy, Thiébaut, Sophie P., Cortaredona, Sébastien, Lerouge, M. Aliénor, Cecchini, Michele, Feigl, Andrea B., Ventelou, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485835/
https://www.ncbi.nlm.nih.gov/pubmed/32915826
http://dx.doi.org/10.1371/journal.pone.0238565
_version_ 1783581226555146240
author Goryakin, Yevgeniy
Thiébaut, Sophie P.
Cortaredona, Sébastien
Lerouge, M. Aliénor
Cecchini, Michele
Feigl, Andrea B.
Ventelou, Bruno
author_facet Goryakin, Yevgeniy
Thiébaut, Sophie P.
Cortaredona, Sébastien
Lerouge, M. Aliénor
Cecchini, Michele
Feigl, Andrea B.
Ventelou, Bruno
author_sort Goryakin, Yevgeniy
collection PubMed
description BACKGROUND: Ageing populations and rising prevalence of non-communicable diseases (NCDs) increasingly contribute to the growing cost burden facing European healthcare systems. Few studies have attempted to quantify the future magnitude of this burden at the European level, and none of them consider the impact of potential changes in risk factor trajectories on future health expenditures. METHODS: The new microsimulation model forecasts the impact of behavioural and metabolic risk factors on NCDs, longevity and direct healthcare costs, and shows how changes in epidemiological trends can modify those impacts. Economic burden of NCDs is modelled under three scenarios based on assumed future risk factors trends: business as usual (BAU); best case and worst case predictions (BCP and WCP). FINDINGS: The direct costs of NCDs in the EU 27 countries and the UK (in constant 2014 prices) will grow under all scenarios. Between 2014 and 2050, the overall healthcare spending is expected to increase by 0.8% annually under BAU. In the all the countries, 605 billion Euros can be saved by 2050 if BCP is realized compared to the BAU, while excess spending under the WCP is forecast to be around 350 billion. Interpretation: Although the savings realised under the BCP can be substantial, population ageing is a stronger driver of rising total healthcare expenditures in Europe compared to scenario-based changes in risk factor prevalence.
format Online
Article
Text
id pubmed-7485835
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74858352020-09-21 Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios Goryakin, Yevgeniy Thiébaut, Sophie P. Cortaredona, Sébastien Lerouge, M. Aliénor Cecchini, Michele Feigl, Andrea B. Ventelou, Bruno PLoS One Research Article BACKGROUND: Ageing populations and rising prevalence of non-communicable diseases (NCDs) increasingly contribute to the growing cost burden facing European healthcare systems. Few studies have attempted to quantify the future magnitude of this burden at the European level, and none of them consider the impact of potential changes in risk factor trajectories on future health expenditures. METHODS: The new microsimulation model forecasts the impact of behavioural and metabolic risk factors on NCDs, longevity and direct healthcare costs, and shows how changes in epidemiological trends can modify those impacts. Economic burden of NCDs is modelled under three scenarios based on assumed future risk factors trends: business as usual (BAU); best case and worst case predictions (BCP and WCP). FINDINGS: The direct costs of NCDs in the EU 27 countries and the UK (in constant 2014 prices) will grow under all scenarios. Between 2014 and 2050, the overall healthcare spending is expected to increase by 0.8% annually under BAU. In the all the countries, 605 billion Euros can be saved by 2050 if BCP is realized compared to the BAU, while excess spending under the WCP is forecast to be around 350 billion. Interpretation: Although the savings realised under the BCP can be substantial, population ageing is a stronger driver of rising total healthcare expenditures in Europe compared to scenario-based changes in risk factor prevalence. Public Library of Science 2020-09-11 /pmc/articles/PMC7485835/ /pubmed/32915826 http://dx.doi.org/10.1371/journal.pone.0238565 Text en © 2020 Goryakin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Goryakin, Yevgeniy
Thiébaut, Sophie P.
Cortaredona, Sébastien
Lerouge, M. Aliénor
Cecchini, Michele
Feigl, Andrea B.
Ventelou, Bruno
Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios
title Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios
title_full Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios
title_fullStr Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios
title_full_unstemmed Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios
title_short Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios
title_sort assessing the future medical cost burden for the european health systems under alternative exposure-to-risks scenarios
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485835/
https://www.ncbi.nlm.nih.gov/pubmed/32915826
http://dx.doi.org/10.1371/journal.pone.0238565
work_keys_str_mv AT goryakinyevgeniy assessingthefuturemedicalcostburdenfortheeuropeanhealthsystemsunderalternativeexposuretorisksscenarios
AT thiebautsophiep assessingthefuturemedicalcostburdenfortheeuropeanhealthsystemsunderalternativeexposuretorisksscenarios
AT cortaredonasebastien assessingthefuturemedicalcostburdenfortheeuropeanhealthsystemsunderalternativeexposuretorisksscenarios
AT lerougemalienor assessingthefuturemedicalcostburdenfortheeuropeanhealthsystemsunderalternativeexposuretorisksscenarios
AT cecchinimichele assessingthefuturemedicalcostburdenfortheeuropeanhealthsystemsunderalternativeexposuretorisksscenarios
AT feiglandreab assessingthefuturemedicalcostburdenfortheeuropeanhealthsystemsunderalternativeexposuretorisksscenarios
AT venteloubruno assessingthefuturemedicalcostburdenfortheeuropeanhealthsystemsunderalternativeexposuretorisksscenarios